Ionis Pharmaceuticals earnings were -$565.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IONS earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$114.6M, up 23.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IONS reported annual earnings of -$381.4M, with -16% growth. The next IONS earnings date is Nov 4, 2026.
Ionis Pharmaceuticals Earnings Reports & History FAQ
What were Ionis Pharmaceuticals's earnings last quarter?
On IONS's earnings call on Jul 29, 2026, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 2026 earnings per share (EPS) of -$0.69, up 188.46% year over year. Total IONS earnings for the quarter were -$114.65 million. In the same quarter last year, Ionis Pharmaceuticals's earnings per share (EPS) was $0.78.
The next IONS earnings call is Nov 4, 2026. Add IONS to your watchlist to be reminded of Ionis Pharmaceuticals's next earnings date.
Is Ionis Pharmaceuticals profitable or losing money?
As of the last Ionis Pharmaceuticals earnings report, Ionis Pharmaceuticals is currently losing money. Ionis Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$565.17 million, a 110.72% increase year over year.
What was IONS's earnings growth in the past year?
As of Ionis Pharmaceuticals's earnings date in Jul 29, 2026, Ionis Pharmaceuticals's earnings has grown year over year. IONS earnings in the past year totalled -$565.17 million.
What are Ionis Pharmaceuticals's earnings expectations?
The current EPS estimate for Ionis Pharmaceuticals's earnings report in Nov 4, 2026 is -$1.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.